Mitochondrial Myopathy Diagnosis & Treatment Market to Reach USD 33.9 Million by 2032 Global mitochondrial myopathy diagnosis & treatment market is gaining measurable momentum as advances in genetic medicine, orphan drug development, and rare disease awareness reshape neuromuscular care. Valued at USD 22.6 million in 2024, the market is projected to grow from USD 23.9 million in 2025 to USD 33.9 million by 2032, registering a CAGR of 6.1% over the forecast period. This expansion reflects sustained investment in targeted therapies, improving diagnostic precision, and rising prioritization of lifelong care for pediatric-onset mitochondrial disorders. Access the market report https://www.24lifesciences.com/mitochondrial-myopathy-diagnosis-treatment-market-9538